healthneutral
The Silent Return of an Ancient Foe
Kansas City, USAMonday, March 24, 2025
The COVID-19 pandemic has played a significant role in TB's resurgence. Globally, TB cases increased by 4. 6 percent from 2020 to 2023, reversing decades of decline. In the U. S. , cases rose by over 15 percent from 2022 to 2023. Lockdowns and fear of COVID-19 made it difficult for people to access healthcare, leading to nearly 700, 000 excess TB deaths. Medical supply shortages and delays also contributed to this uptick.
Treating TB is complex. Before the late 1930s, treatments included bloodletting, cod liver oil, and sanatoriums in high-altitude areas. The first antibiotic, streptomycin, became available in the 1940s, but resistance developed quickly. Isoniazid followed in the 1950s, with similar issues. Today, multidrug treatments are used, but they are toxic and require at least six months of uninterrupted therapy. Early detection and treatment are crucial to prevent the spread of the disease and the development of drug-resistant strains.
People need to understand that TB is still a global health issue. Education about its transmission, treatment, and the need for eradication efforts is vital. Many people with latent TB may not know they have it, as they show no symptoms. Without awareness and testing, these individuals may unknowingly spread the disease.
Actions
flag content